Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis
ConclusionsThese findings, combined with the safety and efficacy data, indicated limited clinical relevance of body-weight effect on sarilumab exposure. No adjustment in sarilumab dose is required for body weight or any other demographics assessed.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Drugs & Pharmacology | Men | Rheumatoid Arthritis | Rheumatology | Statistics | Study